Current Advances and Limitations in Modeling ALS/FTD in a Dish Using Induced Pluripotent Stem Cells

Area of Science:

• Neuroscience
• Stem Cell Biology
• Genetics

Background:

• Amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) are complex neurodegenerative disorders affecting motor neurons and cerebral cortex neurons.
• These conditions share overlapping clinical, genetic, and pathological features, necessitating advanced research models.
• Human induced pluripotent stem cells (iPSCs) derived from patients provide a unique platform for studying these diseases.

Purpose of the Study:

• To review the current state of induced pluripotent stem cell (iPSC) models for amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD).
• To discuss the advancements in generating iPSC-derived neuronal and non-neuronal cells for disease modeling.
• To identify challenges and propose solutions for developing more reliable iPSC-based disease models.

Main Methods:

• Generation of patient-specific induced pluripotent stem cells (iPSCs) from somatic cells.
• Differentiation protocols to obtain iPSC-derived motor neurons, cortical neurons, and non-neuronal cells.
• Analysis of iPSC-derived cells for disease-relevant phenotypes.

Main Results:

• iPSC technology enables the creation of in vitro models for both familial and sporadic forms of ALS and FTD.
• Significant technical progress has been made in iPSC generation and differentiation.
• A key challenge remains in validating whether iPSC-derived cells accurately recapitulate disease phenotypes.

Conclusions:

• iPSC models hold significant promise for understanding the mechanisms of ALS and FTD.
• Further validation and refinement are crucial for establishing trustworthy iPSC-based disease models.
• Continued research in iPSC technology will advance the study and potential treatment of these neurodegenerative disorders.